Patents by Inventor Stephen Andrew Berry

Stephen Andrew Berry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEXATION OF METAL IONS WITH POLYPEPTIDES
    Publication number: 20120122782
    Abstract: Formulations and methods are provided for improving the stability upon exposure to aqueous media of polypeptides present in non-aqueous suspension vehicles. In particular aspects of the invention, formulations are provided that comprise a complex of a metal ion and a polypeptide suspended in a non-aqueous, biocompatible suspension vehicle. Aggregation of individual polypeptide molecules is reduced when aqueous media is introduced to such formulations, serving to stabilize the polypeptide.
    Type: Application
    Filed: November 21, 2011
    Publication date: May 17, 2012
    Inventors: Catherine M. Rohloff, Guohua Chen, Zhongli Ding, Stephen Andrew Berry, Latha Pisharody Narayanan, Michael Desjardin
  • Polyoxaester suspending vehicles for use with implantable delivery systems
    Patent number: 8114430
    Abstract: Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: February 14, 2012
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Catherine Manya Rohloff, Stephen Andrew Berry, Ling-Ling Kang, Aruna Nathan
  • POLYOXAESTER SUSPENDING VEHICLES FOR USE WITH IMPLANTABLE DELIVERY SYSTEMS
    Publication number: 20110264076
    Abstract: Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.
    Type: Application
    Filed: May 3, 2011
    Publication date: October 27, 2011
    Inventors: Catherine Manya Rohloff, Stephen Andrew Berry, Ling-Ling Kang, Aruna Nathan
  • Polyoxaester suspending vehicles for use with implantable delivery systems
    Patent number: 7959938
    Abstract: Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: June 14, 2011
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Catherine Manya Rohloff, Stephen Andrew Berry, Ling-Ling Kang, Aruna Nathan
  • Osmotic beneficial agent delivery system
    Publication number: 20030083647
    Abstract: An osmotic beneficial agent delivery system includes an implantable osmotic delivery device and a catheter for delivery of the beneficial agent from the delivery device to a delivery location. The beneficial agent delivery system includes a catheter and a docking station which are implanted in the patient with a distal end of the catheter positioned at a delivery site. The catheter and docking station are left in place while an implant containing the beneficial agent is removably connected to the catheter at the docking station and can be replaced as needed. The docking station provides a connection between a catheter and the implant allowing the implant to be replaced periodically while the catheter and the docking station remain in place.
    Type: Application
    Filed: November 27, 2002
    Publication date: May 1, 2003
    Inventors: Pamela Fereira, Craig R. Davis, Stephen Andrew Berry, Gregory Stewart, Judy A. Magruder, Wouter E. Roorda, Li-Ming Lau, Paul R. Magruder, Juan M.E. Harrison
  • Osmotic beneficial agent delivery system
    Publication number: 20020032401
    Abstract: An osmotic beneficial agent delivery system includes an implantable osmotic delivery device and a catheter for delivery of the beneficial agent from the delivery device to a delivery location. The beneficial agent delivery system includes a catheter and a docking station which are implanted in the patient with a distal end of the catheter positioned at a delivery site. The catheter and docking station are left in place while an implant containing the beneficial agent is removably connected to the catheter at the docking station and can be replaced as needed. The docking station provides a connection between a catheter and the implant allowing the implant to be replaced periodically while the catheter and the docking station remain in place.
    Type: Application
    Filed: December 27, 2000
    Publication date: March 14, 2002
    Inventors: Pamela Fereira, Craig R. Davis, Stephen Andrew Berry, Gregory Stewart, Judy A. Magruder, Wouter E. Roorda, Li-Ming Lau, Paul R. Magruder, Juan M.E. Harrison